Patents by Inventor Anderson Gaweco

Anderson Gaweco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ROR MODULATORS AND THEIR USES
    Publication number: 20150073016
    Abstract: The invention relates to ROR modulators; compositions comprising an effective amount of a ROR modulator; and methods for treating or preventing diseases associated with ROR.
    Type: Application
    Filed: April 30, 2013
    Publication date: March 12, 2015
    Inventors: Anderson GAWECO, Jefferson TILLEY, John WALKER, Samantha PALMER, James BLINN
  • MIF INHIBITORS AND THEIR USES
    Publication number: 20150065480
    Abstract: The invention relates to MIF inhibitors; compositions comprising an effective amount of a MIF inhibitor; and methods for treating or preventing diseases associated with MIF.
    Type: Application
    Filed: April 13, 2012
    Publication date: March 5, 2015
    Applicant: INNOVIMMUNE BIOTHERAPEUTICS, INC.
    Inventors: Anderson Gaweco, John Walker, Joseph B. Monahan, Jerry W. Cubbage, Jeffery Carroll
  • MIF INHIBITORS AND THEIR USES
    Publication number: 20120035150
    Abstract: The invention relates to MIF inhibitors; compositions comprising an effective amount of a MIF inhibitor; and methods for treating or preventing diseases associated with MIF.
    Type: Application
    Filed: July 15, 2011
    Publication date: February 9, 2012
    Inventors: Anderson Gaweco, John K. Walker, Joseph B. Monahan, Jerry W. Cubbage, Jeffery Carroll
  • Modified stent useful for delivery of drugs along stent strut
    Publication number: 20050137679
    Abstract: Delivery of Janus Kinase 3 (JAK3) inhibitor locally, particularly from an intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention facilitates the performance of the stent in inhibiting restonosis.
    Type: Application
    Filed: December 13, 2004
    Publication date: June 23, 2005
    Inventors: Paul Changelian, Anderson Gaweco
  • Stent with therapeutically active drug coated thereon
    Publication number: 20050137684
    Abstract: Delivery of a Janus Kinase 3 (JAK3) inhibitor locally, particularly from an intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis.
    Type: Application
    Filed: December 13, 2004
    Publication date: June 23, 2005
    Inventors: Paul Changelian, Anderson Gaweco